Entrada Therapeutics Statistics

Total Valuation

TRDA has a market cap or net worth of $310.96 million. The enterprise value is -$13.14 million.

Market Cap	310.96M
Enterprise Value	-13.14M

Important Dates

The last earnings date was Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TRDA has 35.26 million shares outstanding. The number of shares has increased by 20.56% in one year.

Current Share Class	35.26M
Shares Outstanding	35.26M
Shares Change (YoY)	+20.56%
Shares Change (QoQ)	-4.59%
Owned by Insiders (%)	1.09%
Owned by Institutions (%)	53.14%
Float	18.65M

Valuation Ratios

The trailing PE ratio is 14.54.

PE Ratio	14.54
Forward PE	n/a
PS Ratio	1.91
Forward PS	6.81
PB Ratio	0.71
P/TBV Ratio	0.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.88, with a Debt / Equity ratio of 0.14.

Current Ratio	21.88
Quick Ratio	21.00
Debt / Equity	0.14
Debt / EBITDA	2.72
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 7.22% and return on invested capital (ROIC) is 0.63%.

Return on Equity (ROE)	7.22%
Return on Assets (ROA)	0.51%
Return on Invested Capital (ROIC)	0.63%
Return on Capital Employed (ROCE)	0.88%
Revenue Per Employee	$941,093
Profits Per Employee	$135,415
Employee Count	183
Asset Turnover	0.35
Inventory Turnover	n/a

Taxes

Income Tax	-972,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.49% in the last 52 weeks. The beta is 0.03, so TRDA's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	-38.49%
50-Day Moving Average	9.31
200-Day Moving Average	14.43
Relative Strength Index (RSI)	49.59
Average Volume (20 Days)	141,388

Short Selling Information

The latest short interest is 1.06 million, so 3.02% of the outstanding shares have been sold short.

Short Interest	1.06M
Short Previous Month	1.10M
Short % of Shares Out	3.02%
Short % of Float	5.71%
Short Ratio (days to cover)	6.01

Income Statement

In the last 12 months, TRDA had revenue of $172.22 million and earned $24.78 million in profits. Earnings per share was $0.61.

Revenue	172.22M
Gross Profit	43.45M
Operating Income	4.11M
Pretax Income	40.51M
Net Income	24.78M
EBITDA	7.89M
EBIT	4.11M
Earnings Per Share (EPS)	$0.61

Full Income Statement

Balance Sheet

The company has $382.52 million in cash and $57.00 million in debt, giving a net cash position of $325.52 million or $9.23 per share.

Cash & Cash Equivalents	382.52M
Total Debt	57.00M
Net Cash	325.52M
Net Cash Per Share	$9.23
Equity (Book Value)	417.26M
Book Value Per Share	11.84
Working Capital	384.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$54.55 million and capital expenditures -$3.46 million, giving a free cash flow of -$58.01 million.

Operating Cash Flow	-54.55M
Capital Expenditures	-3.46M
Free Cash Flow	-58.01M
FCF Per Share	-$1.65

Full Cash Flow Statement

Margins

Gross margin is 25.23%, with operating and profit margins of 2.39% and 14.39%.

Gross Margin	25.23%
Operating Margin	2.39%
Pretax Margin	13.82%
Profit Margin	14.39%
EBITDA Margin	4.58%
EBIT Margin	2.39%
FCF Margin	n/a

Dividends & Yields

TRDA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.56%
Shareholder Yield	-20.56%
Earnings Yield	7.93%
FCF Yield	-18.57%

Analyst Forecast

The average price target for TRDA is $25.67, which is 191.04% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.67
Price Target Difference	191.04%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	-34.72%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TRDA has an Altman Z-Score of 5.46 and a Piotroski F-Score of 4.

Altman Z-Score	5.46
Piotroski F-Score	4